144 related articles for article (PubMed ID: 31274696)
21. Meta-analysis of double-blind placebo-controlled trials of antidepressants and benzodiazepines for patients with panic disorders.
Wilkinson G; Balestrieri M; Ruggeri M; Bellantuono C
Psychol Med; 1991 Nov; 21(4):991-8. PubMed ID: 1685792
[TBL] [Abstract][Full Text] [Related]
22. Benzodiazepines and anxiety disorders: a review for the practicing physician.
Michael Kaplan E; DuPont RL
Curr Med Res Opin; 2005 Jun; 21(6):941-50. PubMed ID: 15969894
[TBL] [Abstract][Full Text] [Related]
23. Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications.
Casacalenda N; Boulenger JP
Can J Psychiatry; 1998 Sep; 43(7):722-30. PubMed ID: 9773222
[TBL] [Abstract][Full Text] [Related]
24. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
[TBL] [Abstract][Full Text] [Related]
25. Duloxetine in treating generalized anxiety disorder in adults: A meta-analysis of published randomized, double-blind, placebo-controlled trials.
Zhang Y; Huang G; Yang S; Liang W; Zhang L; Wang C
Asia Pac Psychiatry; 2016 Sep; 8(3):215-25. PubMed ID: 26238298
[TBL] [Abstract][Full Text] [Related]
26. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
27. Antidepressants for depression in patients with dementia: a review of the literature.
Leong C
Consult Pharm; 2014 Apr; 29(4):254-63. PubMed ID: 24704894
[TBL] [Abstract][Full Text] [Related]
28. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
Dunner DL; Ishiki D; Avery DH; Wilson LG; Hyde TS
J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
[TBL] [Abstract][Full Text] [Related]
29. Comparative efficacy of antidepressants in preventing relapse in anxiety disorders - a meta-analysis.
Donovan MR; Glue P; Kolluri S; Emir B
J Affect Disord; 2010 Jun; 123(1-3):9-16. PubMed ID: 19616306
[TBL] [Abstract][Full Text] [Related]
30. Current use of benzodiazepines in anxiety disorders.
Cloos JM; Ferreira V
Curr Opin Psychiatry; 2009 Jan; 22(1):90-5. PubMed ID: 19122540
[TBL] [Abstract][Full Text] [Related]
31. Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials.
Katz IR; Reynolds CF; Alexopoulos GS; Hackett D
J Am Geriatr Soc; 2002 Jan; 50(1):18-25. PubMed ID: 12028242
[TBL] [Abstract][Full Text] [Related]
32. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.
Moylan S; Staples J; Ward SA; Rogerson J; Stein DJ; Berk M
J Clin Psychopharmacol; 2011 Oct; 31(5):647-52. PubMed ID: 21869686
[TBL] [Abstract][Full Text] [Related]
33. Second-generation antipsychotics for anxiety disorders.
Depping AM; Komossa K; Kissling W; Leucht S
Cochrane Database Syst Rev; 2010 Dec; (12):CD008120. PubMed ID: 21154392
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of generalized anxiety: new pharmacologic approaches].
Boulenger JP
Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
[TBL] [Abstract][Full Text] [Related]
35. Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial.
Hadley SJ; Mandel FS; Schweizer E
J Psychopharmacol; 2012 Apr; 26(4):461-70. PubMed ID: 21693549
[TBL] [Abstract][Full Text] [Related]
36. Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation.
Rickels K; Schweizer E; Case WG; Greenblatt DJ
Arch Gen Psychiatry; 1990 Oct; 47(10):899-907. PubMed ID: 2222129
[TBL] [Abstract][Full Text] [Related]
37. An evaluation of the anxiolytic SC 48,274 in generalized anxiety disorder (GAD).
Cutler NR; Sramek JJ; Macpherson AE; Doss MG; Benes CO; Howard SF
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):685-94. PubMed ID: 7938559
[TBL] [Abstract][Full Text] [Related]
38. The pharmacologic treatment of anxiety disorders: a review of progress.
Ravindran LN; Stein MB
J Clin Psychiatry; 2010 Jul; 71(7):839-54. PubMed ID: 20667290
[TBL] [Abstract][Full Text] [Related]
39. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
[TBL] [Abstract][Full Text] [Related]
40. Drug treatment of panic disorder--a critical review of controlled clinical trials.
Balestrieri M; Ruggeri M; Bellantuono C
Psychiatr Dev; 1989; 7(4):337-50. PubMed ID: 2577301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
